What is an appropriate follow-up for a patient currently taking a statin?

When managing a patient on a statin, it is important to periodically reassess their atherosclerotic cardiovascular disease (ASCVD) risk. Statins are used not only for lowering cholesterol levels but also for reducing the overall risk of cardiovascular events. As a patient’s clinical status may change over time, including new risk factors or changes in comorbidity, it is essential to evaluate their ASCVD risk periodically to ensure that they are on the most appropriate treatment for their current risk level.

A reassessment allows for adjustments in therapy if necessary, ensuring that the patient continues to receive the full benefits of statin therapy based on the most recent evidence regarding their cardiovascular risk profile. This proactive approach helps in tailoring treatment to better meet the patient's needs and enhancing patient outcomes.

Monitoring liver function tests is relevant in the context of statin therapy, but it is typically not required every month, particularly if there are no concerning symptoms or risk factors. Side effects should be taken into account when managing patient therapy, but treatment adjustments should involve a broader consideration of therapeutic goals beyond just side effects. Lastly, discontinuing therapy after a set period without considering ongoing necessity or the patient’s current ASCVD risk may lead to increased cardiovascular risk. Continuing therapy or reassessing based